Cyclacel Pharmaceuticals, Inc.
CYCC
$7.99
-$0.01-0.13%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 23.91% | 9.98% | 5.20% | -50.30% | 114.44% |
| Total Receivables | -- | -- | -- | 28.13% | -27.48% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -28.57% | -70.46% | -36.63% | -13.63% | 31.61% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -70.10% | -35.33% | -2.91% | 3.00% | -17.81% |
| Total Current Assets | 18.01% | 1.09% | -25.22% | -36.25% | 59.40% |
|
|
|||||
| Total Current Assets | 18.01% | 1.09% | -25.22% | -36.25% | 59.40% |
| Net Property, Plant & Equipment | -10.00% | 150.00% | -85.45% | -21.43% | -18.60% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -0.24% | 0.00% | -66.80% |
| Total Assets | 17.86% | -8.79% | -23.92% | -34.30% | 32.85% |
|
|
|||||
| Total Accounts Payable | 93.86% | -97.52% | 11.46% | -12.97% | -8.83% |
| Total Accrued Expenses | -5.83% | -61.62% | -26.78% | -7.66% | -28.17% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 123.53% | -93.99% | -14.76% | -15.95% | 33.45% |
| Total Other Current Liabilities | 123.53% | -93.99% | -14.76% | -15.95% | 33.45% |
| Total Current Liabilities | 14.63% | -89.42% | -1.31% | -11.62% | -13.94% |
|
|
|||||
| Total Current Liabilities | 14.63% | -89.42% | -1.31% | -11.62% | -13.94% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 11.11% | -- | -- | -- | -76.19% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 14.58% | -89.28% | -1.31% | -11.68% | -14.10% |
|
|
|||||
| Common Stock & APIC | 0.43% | 1.21% | 0.39% | 0.02% | 1.51% |
| Retained Earnings | -0.30% | -0.22% | -0.70% | -0.45% | -0.76% |
| Treasury Stock & Other | -- | 100.11% | 13.75% | -12.90% | -1.89% |
| Total Common Equity | 18.48% | 240.85% | -124.12% | -197.10% | 145.29% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 18.48% | 240.85% | -124.12% | -197.10% | 145.29% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 18.58% | 240.85% | -124.12% | -197.10% | 145.29% |
|
|
|||||